CLL Global Research Foundation

 

Upcoming Events
  • Home
  • CLL Information
    • Biology
    • Age & Symptoms
    • Diagnosis
    • Immunology
    • Prognostic Factors
    • Treatments
    • Familial CLL
    • Other
  • News & Views
    • Latest News
    • Upcoming Events
    • President’s Corner
    • Newsletters
    • Multimedia
  • Funded Research
    • Individual Grants
    • Alliance Grants
    • Research Success
    • Other Funding
  • Grant Applications
  • About
    • About Us
    • Mission & Objectives
    • Board of Directors
    • Scientific Advisory Board
  • Donate
  • Contact Us

Gene and Vaccine Therapy

View Gene and Vaccine Therapy Funded Projects

Participants working together on gene and vaccine therapy include:

wierda
William Wierda, M.D., Ph.D., Working Group Chair
University of Texas MD Anderson Cancer Center
hillman
Peter Hillmen, M.D., Ph.D.
Pinderfields Hospital (United Kingdom)
kipps
Thomas Kipps, M.D., Ph.D.
University of California, San Diego
Rebecca and John Moores Cancer Center
melstedt
Håkan Mellstedt, M.D., Ph.D.
Karolinska University Hospital (Sweden)
osterborg
Anders Österborg, M.D.
Karolinska University Hospital (Sweden)
rawstron
Andy Rawstron, Ph.D.
Leeds Teaching Hospitals NHS Trust (United Kingdom)
wendtner
Clemens Wendtner, M.D.
University of Cologne (Germany)
Donate to CLL
Join Our Mailing List

CLL: Where We Have Been and Looking to the Future

Renowned CLL experts Dr. Michael Keating and Dr. William Wierda talk with Patient Power Founder Andrew Schorr about the evolution of CLL care and the ways CLL Global Research Foundation is investing in the future.

Watch the interview


CLL GLOBAL RESEARCH FOUNDATION

P.O. Box 301402
Houston, TX 77230

MISSION STATEMENT

Our mission is to abolish chronic lymphocytic leukemia (CLL) as a threat to the life and health of patients by accelerating CLL research.

NEWSLETTER

Join Our Mailing List

Join Us on facebook

f_logo small

Copyright © 2023 CLL Global · Website designed by White Space Web Studio · Log in